PNC Financial Services Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.48K Buy
3,273
+3,229
+7,339% +$6.34K ﹤0.01% 4551
2026
Q2
$107 Buy
+44
New +$108 ﹤0.01% 5140
2026
Q1
– Sell
-5
Closed -$26 – 5274
2025
Q4
$26 Hold
5
– – ﹤0.01% 5124
2025
Q3
$21 Hold
5
– – ﹤0.01% 5059
2025
Q2
$18 Buy
+5
New +$19 ﹤0.01% 4888
2024
Q1
– Sell
-12
Closed -$49 – 4780
2023
Q4
$49 Buy
+12
New +$34 ﹤0.01% 4567
2023
Q2
– Sell
-284
Closed -$605 – 4806
2023
Q1
$605 Sell
284
-2,495
-90% -$6.16K ﹤0.01% 4505
2022
Q4
$7.48K Sell
2,779
-3,979
-59% -$11.6K ﹤0.01% 3870
2022
Q3
$22K Buy
6,758
+2,180
+48% +$9.9K ﹤0.01% 3401
2022
Q2
$23K Buy
4,578
+1,211
+36% +$7.45K ﹤0.01% 3434
2022
Q1
$26K Sell
3,367
-1,213
-26% -$9.39K ﹤0.01% 3450
2021
Q4
$42K Buy
4,580
+2,258
+97% +$24K ﹤0.01% 3207
2021
Q3
$33K Buy
2,322
+327
+16% +$5.08K ﹤0.01% 3295
2021
Q2
$34K Buy
+1,995
New +$37.2K ﹤0.01% 3256

Other funds holding ORGO

PNC Financial Services Group's ORGO Position: Q3 2026 in Review

PNC Financial Services Group increased its Organogenesis Holdings (ORGO) stake by 7,339% in Q3 2026, buying an estimated $6.34K and bringing the position to 3,273 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4551.

PNC Financial Services Group first reported a position in ORGO in Q2 2021 and has held it in 14 quarters since. The position peaked at $42K in Q4 2021. 54 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • PNC Financial Services Group held 3,273 shares of Organogenesis Holdings worth $4.48K as of Q3 2026.
  • PNC Financial Services Group bought 3,229 Organogenesis Holdings shares in Q3 2026, an estimated $6.34K.
  • Organogenesis Holdings made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4551 holding.
  • PNC Financial Services Group first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 14 quarters since.
  • PNC Financial Services Group's Organogenesis Holdings position peaked at $42K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.